Major Breakthrough in Treatment for Severe Hemophilia A

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

This video from Wochit News is all about a new treatment for severe hemophilia A. The Children’s Hospital of Los Angeles, California, has developed a breakthrough treatment that can reduce the bleeding episodes in people living with hemophilia A by up to 90 percent.

MORE: Emicizumab shows promise in trials as a preventative treatment for hemophilia A patients of all ages

Currently, people who have severe hemophilia A need to have hour-long intravenous clotting factor treatments three times a week to help prevent bleeds. The research team at the hospital found that the monoclonal antibody emicizumab dramatically decreased the bleeding episodes for hemophilia A patients, and the treatment only needs to be given once a week by subcutaneous injection.

MORE: Chugai Pharmaceutical files new drug application for hemophilia A treatment emicizumab

Hemophilia News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.